Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Weekly 20/56 mg/m² carfilzomib, lenalidomide and dexamethasone until progression in early relapsed refractory multiple myeloma

Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France

$Weekly 20/56 mg/m² carfilzomib, lenalidomide and dexamethasone until progression in early relapsed refractory multiple myeloma ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )$

Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma

Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France

Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )

ZUMA-3: A study of KTE-X19 in adults with relapsed/refractory acute lymphoblastic leukaemia

Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA

$ZUMA-3: A study of KTE-X19 in adults with relapsed/refractory acute lymphoblastic leukaemia ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )$

Better education about breast cancer treatment in Africa

Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International, Accra, Ghana

Better education about breast cancer treatment in Africa ( Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International, Accra, Ghana )

A severe lack of cancer care in Burundi

Dr Canesius Uwizeyimana - Radiation Oncology Medical Physicist, Bujumbura, Burundi

A severe lack of cancer care in Burundi ( Dr Canesius Uwizeyimana - Radiation Oncology Medical Physicist, Bujumbura, Burundi )

Predictive models for treatment risk in cancer

Dr Charlotte Moser - Founder weCancerTALK

Predictive models for treatment risk in cancer ( Dr Charlotte Moser - Founder weCancerTALK )

Improving radiotherapy access in Africa

Dow Wilson - CEO, Varian Medical Systems

Improving radiotherapy access in Africa ( Dow Wilson - CEO, Varian Medical Systems )

The global program of the American Cancer Society

Dr Meg O'Brien - American Cancer Society, Atlanta, USA

The global program of the American Cancer Society ( Dr Meg O'Brien - American Cancer Society, Atlanta, USA )

Improving communication and collaboration to tackle cancer in Africa

Prof Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA

Improving communication and collaboration to tackle cancer in Africa ( Prof Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA )

Barriers to cancer care in Africa

Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Barriers to cancer care in Africa ( Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania )

The Global Health Catalyst initiative

Wilfred Ngwa - Harvard Medical School. Boston, Massachusetts

The Global Health Catalyst initiative ( Wilfred Ngwa - Harvard Medical School. Boston, Massachusetts )

The future potential of cannabis in healthcare

Prof Henry Lowe - CEO Medicanja, Kingston, Jamaica

The future potential of cannabis in healthcare ( Prof Henry Lowe - CEO Medicanja, Kingston, Jamaica )

More from ecancer